Synthesis and preliminary PET imaging of (11)C and (18)F isotopologues of the ROS1/ALK inhibitor lorlatinib

Lorlatinib (PF-06463922) is a next-generation small-molecule inhibitor of the orphan receptor tyrosine kinase c-ros oncogene 1 (ROS1), which has a kinase domain that is physiologically related to anaplastic lymphoma kinase (ALK), and is undergoing Phase I/II clinical trial investigations for non-sma...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Nat Commun
Glavni autori: Collier, Thomas Lee, Normandin, Marc D., Stephenson, Nickeisha A., Livni, Eli, Liang, Steven H., Wooten, Dustin W., Esfahani, Shadi A., Stabin, Michael G., Mahmood, Umar, Chen, Jianqing, Wang, Wei, Maresca, Kevin, Waterhouse, Rikki N., El Fakhri, Georges, Richardson, Paul, Vasdev, Neil
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5472746/
https://ncbi.nlm.nih.gov/pubmed/28594000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms15761
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items